Johnson & Johnson Executive Speaking At Goldman Sachs Healthcare Conference Says Psoriasis Pill Icotyde Has Roughly 4,500 Prescribers Now, DTC Campaign Is Expected Soon
Johnson & Johnson Executive Speaking At Goldman Sachs Healthcare Conference Says Psoriasis Pill Icotyde Has Roughly 4,500 Prescribers Now, DTC Campaign Is Expected Soon
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day